Skip to main content


2021 Virtual CME Series
Practical Approaches and Targeted Therapies in Lung Cancer
25 Years & Counting

Join us for an educational experience designed for modern-day practitioners, treatment methods, and practice guidelines shaping the future of how we care for patients with lung cancer.

Crafted by nationally renowned experts in the field of thoracic oncology, this 3-day event will equip you with the latest advancements and practical education on targeted therapies, biomarker testing, and precision medicine that you can immediately put to use in your practice. 

Engage in live Q&A with presenters, network with colleagues and conveniently access all of the educational content on demand for 6 months. We remain committed to providing you with an unmatched educational experience, regardless of the format. 

Together, we will continue to move forward, push boundaries, and overcome obstacles to advance our field, and most importantly, the lives of our patients.

Virtual Platform
Going Beyond Traditional Treatment Methods

We're bringing together the most experienced and engaging speakers to address the most critical and controversial topics in the field.

Years of Success
Thought Leaders
CME Credits
Who Should Attend?

This activity is designed to meet the educational needs of all healthcare professionals interested in the care and treatment of patients with thoracic malignancies.

Medical Oncologists
Radiation Oncologists
Thoracic Surgeons
Diagnostic Radiologists
Clinical Researchers & Research Personnel
Nurse Practitioners
Physician Assistants
Meet the Chairs
Meeting Chair
Corey Langer, MD
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA
Co-Chair (Nov.)
Joel W. Neal, MD, PhD
Stanford Cancer Center
Stanford University Medical Center
Stanford, CA
What sets Perspectives in Thoracic Oncology apart from other conferences in the lung cancer space are the true thoracic experts that share relevant updates and perspectives in an intimate setting. I am looking forward to discussing the emerging strategies for adjuvant therapies in early stage NSCLC."

Christine Ciunci, MD, MSCE
Abramson Cancer Center
University of Pennsylvania 

I have been attending Perspectives in Thoracic Oncology for the last 7 to 8 years and find the breadth of material presented and the depth of discussion of the material rewarding. It has reinforced my current knowledge of the science of lung cancer and its rapidly evolving treatment that includes biologic agents, conventional chemotherapy, radiation therapy, and new approaches. The back and forth discussions of treatment options has been stimulating. I will be attending this year's meeting and into the future."

Gary Smith, MD
Pulmonary Associates of Lubbock
Lubbock, TX

I chose to be a part of Perspectives in Thoracic Oncology because of the cutting edge topics being discussed. I enjoy the smaller, close-knit community feel of this meeting."

Charu Aggarwal, MD
Abramson Cancer Center
University of Pennsylvania 

As a nurse practitioner specializing in lung cancer, I look forward to The Perspectives in Thoracic Oncology Conference each year. I am never disappointed as the topics span from screening and smoking cessation to various treatment modalities, as well as updates on trials. I credit this annual conference to the practice improvements that our multidisciplinary team makes annually."

April Plank, DNP
The Center for Lung Cancer Screening and Prevention
Stony Brook, NY


Keep Me Informed